Skip to main content
IMVT filings

Corporate insider profile

Andrew J. Fromkin Filing Activity

Latest reported as Corporate insider of Immunovant, Inc. (IMVT).

Purchase filings
0
Reported companies
1
Net open-market value
-$7,438,110.69
Latest transaction
May 28, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 28, 2026Immunovant, Inc. (IMVT)Corporate insiderSale221,951$33.51$7,438,111